52 related articles for article (PubMed ID: 8361005)
1. [Anti-endometrial cancer monoclonal antibody "MSN-1" and its application to EmC-EIA method].
Nozawa S; Tsukazaki K; Sakayori M; Kobayashi Y; Kobiki K
Rinsho Byori; 1993 Jun; Suppl 94():147-60. PubMed ID: 8361005
[No Abstract] [Full Text] [Related]
2. [Characterization of anti human uterine endometrial cancer antibody (MSN-1) and its usefulness in clinical application].
Tsukazaki K; Sakuma Y; Kaneta Y; Sakayori M; Uchiyama M; Nozawa S
Gan To Kagaku Ryoho; 1994 Feb; 21(2):141-9. PubMed ID: 8311483
[TBL] [Abstract][Full Text] [Related]
3. [Development of a new supplementary diagnostic method for endometrial cancer by flow cytometry employing anti-endometrial cancer antibody, MSN-1 and MSN-3].
Tsukazaki K; Kobiki K; Hasegawa K; Sakayori M; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2476-83. PubMed ID: 1280307
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical reactivity of antikeratan sulfate monoclonal antibody 5D4 to various conditions of human endometrial tissues and its application as a useful marker for identifying endometrial epithelia.
Shiozawa T; Tsukahara Y; Nakayama J; Ishii K; Katsuyama T
Gynecol Obstet Invest; 1991; 32(4):239-42. PubMed ID: 1778517
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a quantitative assay of abnormal glycolipid expression in endometrial cells, and its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Kubushiro K; Sakayori M; Nozawa S
Clin Cancer Res; 1996 Apr; 2(4):749-54. PubMed ID: 9816226
[TBL] [Abstract][Full Text] [Related]
7. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
Ueda K; Yamada K; Urashima M; Ishibashi Y; Shirai M; Nikaido T; Takahashi H; Okamoto A; Saito M; Yasuda M; Ohkawa K; Tanaka T
Oncol Rep; 2007 Apr; 17(4):731-5. PubMed ID: 17342307
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled monoclonal antibodies for cancer therapy and diagnosis: is it really a chimera?
Sands H
J Nucl Med; 1992 Jan; 33(1):29-32. PubMed ID: 1730992
[No Abstract] [Full Text] [Related]
9. Aggressive endometriosis with focal change suggesting early neoplastic transformation.
Yan M; Boulas J; Russell P
Pathology; 2007 Aug; 39(4):450-3. PubMed ID: 17676492
[No Abstract] [Full Text] [Related]
10. [The endometrium: what kind of imaging?].
Lemercier E; Genevois A; Dacher JN
J Radiol; 2000 Dec; 81(12 Suppl):1857-62. PubMed ID: 11173755
[No Abstract] [Full Text] [Related]
11. Loss of Smad4 protein expression occurs infrequently in endometrial carcinomas.
Liu FS; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Int J Gynecol Pathol; 2003 Oct; 22(4):347-52. PubMed ID: 14501814
[TBL] [Abstract][Full Text] [Related]
12. Acute abdomen caused by endometrial stromal sarcoma arising in extragonadal foci of endometriosis of the terminal ileum.
Budäus LH; Menzel T; Hartmann V; Caselitz J; Doerner A
Int J Colorectal Dis; 2008 Apr; 23(4):447-8. PubMed ID: 17768631
[No Abstract] [Full Text] [Related]
13. Detection of endometrial cancer by flow cytometry using two monoclonal antibodies.
Kobiki K; Tsukasaki K; Kubushiro K; Kobayashi Y; Hasegawa K; Fukuchi T; Banno K; Nozawa S
Cytometry; 1999 Jun; 36(2):150-6. PubMed ID: 10554163
[TBL] [Abstract][Full Text] [Related]
14. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.
Tan EM; Smolen JS; McDougal JS; Fritzler MJ; Gordon T; Hardin JA; Kalden JR; Lahita RG; Maini RN; Reeves WH; Rothfield NF; Takasaki Y; Wiik A; Wilson M; Koziol JA
J Rheumatol; 2002 Jan; 29(1):68-74. PubMed ID: 11824974
[TBL] [Abstract][Full Text] [Related]
15. Use of monoclonal antibodies in solid tumors diagnosis: the endometrial carcinoma.
Bartolazzi A; Mottolese M; Vocaturo A; Vocaturo G; Bigotti A; Prat M; Atlante G; Natali PG
Cytotechnology; 1991; 5 Suppl 1():35-40. PubMed ID: 1367118
[No Abstract] [Full Text] [Related]
16. Frequent immune responses to a cancer/testis antigen, CAGE, in patients with microsatellite instability-positive endometrial cancer.
Iwata T; Fujita T; Hirao N; Matsuzaki Y; Okada T; Mochimaru H; Susumu N; Matsumoto E; Sugano K; Yamashita N; Nozawa S; Kawakami Y
Clin Cancer Res; 2005 May; 11(10):3949-57. PubMed ID: 15897597
[TBL] [Abstract][Full Text] [Related]
17. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of EIA Borrelia recombinant IgM of the 3rd generation with EIA test based on whole cell antigen in the diagnosis of Lyme borreliosis].
Krbková L; Stroblová H
Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):271-8. PubMed ID: 15655723
[TBL] [Abstract][Full Text] [Related]
19. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
20. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
Dittadi R; Meo S; Amoroso B; Gion M
Cancer Res; 1997 Mar; 57(6):1066-72. PubMed ID: 9067273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
